Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

229 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Multicenter phase-II trial of irinotecan plus oxaliplatin [IROX regimen] in patients with poor-prognosis cancer of unknown primary: a hellenic cooperative oncology group study.
Briasoulis E, Fountzilas G, Bamias A, Dimopoulos MA, Xiros N, Aravantinos G, Samantas E, Kalofonos H, Makatsoris T, Mylonakis N, Papakostas P, Skarlos D, Varthalitis I, Pavlidis N. Briasoulis E, et al. Among authors: aravantinos g. Cancer Chemother Pharmacol. 2008 Jul;62(2):277-84. doi: 10.1007/s00280-007-0604-7. Epub 2007 Sep 28. Cancer Chemother Pharmacol. 2008. PMID: 17901952 Clinical Trial.
Intracavitary use of two radiolabeled tumor-associated monoclonal antibodies.
Malamitsi J, Skarlos D, Fotiou S, Papakostas P, Aravantinos G, Vassilarou D, Taylor-Papadimitriou J, Koutoulidis K, Hooker G, Snook D, et al. Malamitsi J, et al. Among authors: aravantinos g. J Nucl Med. 1988 Dec;29(12):1910-5. J Nucl Med. 1988. PMID: 3193206 Free article.
Carboplatin alone compared with its combination with epirubicin and cyclophosphamide in untreated advanced epithelial ovarian cancer: a Hellenic co-operative oncology group study.
Skarlos DV, Aravantinos G, Kosmidis P, Pavlidis N, Gennatas K, Beer M, Mylonakis N, Makrantonakis P, Klouvas G, Karpathios S, Linardou H, Konstantaras C, Fountzilas G. Skarlos DV, et al. Among authors: aravantinos g. Eur J Cancer. 1996 Mar;32A(3):421-8. doi: 10.1016/0959-8049(95)00537-4. Eur J Cancer. 1996. PMID: 8814685 Clinical Trial.
Chemotherapy with methotrexate, vinblastine, epirubicin and carboplatin (Carbo-MVE) in transitional cell urothelial cancer. A Hellenic Co-Operative Oncology Group study.
Skarlos DV, Aravantinos G, Linardou E, Kostakopoulos CA, Kastriotis I, Christodoulou C, Picramenos D, Giannakakis T, Dimopoulos K, Fountzilas G. Skarlos DV, et al. Among authors: aravantinos g. Eur Urol. 1997;31(4):420-7. doi: 10.1159/000474500. Eur Urol. 1997. PMID: 9187901 Clinical Trial.
Paclitaxel with carboplatin versus paclitaxel with carboplatin alternating with cisplatin as first-line chemotherapy in advanced epithelial ovarian cancer: preliminary results of a Hellenic Cooperative Oncology Group study.
Skarlos DV, Aravantinos G, Kosmidis P, Athanassiadis A, Stathopoulos GP, Pavlidis N, Bafaloukos D, Karphathios S, Papakostas P, Bamia C, Fountzilas G. Skarlos DV, et al. Among authors: aravantinos g. Semin Oncol. 1997 Oct;24(5 Suppl 15):S15-57-S15-61. Semin Oncol. 1997. PMID: 9346224 Clinical Trial.
229 results